Natriuretic Peptides in Chronic Kidney Disease | Zendy

Rajat Tagore | Zendy; Lieng H. Ling | Zendy; Hong Yang | Zendy; Hla-Yee Daw | Zendy; YiongHuak Chan | Zendy; Sunil Sethi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Natriuretic Peptides in Chronic Kidney Disease

Author(s) -

Rajat Tagore,

Lieng H. Ling,

Hong Yang,

Hla-Yee Daw,

YiongHuak Chan,

Sunil Sethi

Publication year - 2008

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00850208

Subject(s) - medicine , ejection fraction , cardiology , renal function , natriuretic peptide , kidney disease , heart failure , brain natriuretic peptide , biomarker , biochemistry , chemistry

B-type natriuretic peptide (BNP) and amino-terminal pro-B-type natriuretic peptide (NT-proBNP) are biomarkers of cardiovascular disease that is common in patients with chronic kidney disease (CKD). Conflicting data on the influence of glomerular filtration rate (GFR) on BNP and NT-proBNP levels in CKD may stem from failure to account fully for the effects of coexistent cardiac disease, dysfunction, and volume overload.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research